Literature DB >> 2454781

Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease.

H T Shih1, C R Webb, W A Conway, E Peterson, B Tilley, S Goldstein.   

Abstract

Ambulatory electrocardiograms obtained in 69 patients enrolled in the nocturnal oxygen therapy trial group were examined for frequency and significance of arrhythmias in patients with stable chronic obstructive lung disease. Ventricular premature beats occurred in 83 percent, ventricular bigeminy in 68 percent, paired ventricular premature beats in 61 percent, and nonsustained ventricular tachycardia in 22 percent of the patients. Supraventricular tachycardia occurred in 69 percent. Repetitive ventricular arrhythmia occurred in 64 percent of the patients, and was significantly more frequent in men and in patients with edema or elevated PCO2. Ventricular premature beats greater or equal to 25 per hour occurred in 35 percent of the patients. Univariate and multivariate Cox proportional hazards analysis showed that a history of coronary heart disease, increased sinus heart rate and decreased maximum work load (measured by maximal treadmill exercise test)--but not arrhythmias--were predictors of death.

Entities:  

Mesh:

Year:  1988        PMID: 2454781     DOI: 10.1378/chest.94.1.44

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

2.  Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients.

Authors:  Zehra Husain; Gurunanthan Palani; Rafael Cabrera; Aarthee S Karthikeyan; Sunitha Dhanalakota; Suba Pathmanathan; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  Int J Cardiovasc Imaging       Date:  2011-12-27       Impact factor: 2.357

3.  Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease.

Authors:  Ilker Murat Caglar; Tolga Dasli; Fatma Nihan Turhan Caglar; Mehmet Kamil Teber; Murat Ugurlucan; Gokhan Ozmen
Journal:  Clin Res Cardiol       Date:  2012-03-06       Impact factor: 5.460

4.  Ventricular arrhythmia and sleep-related breathing disorders.

Authors:  Saman Nazarian
Journal:  Heart Rhythm       Date:  2010-12-30       Impact factor: 6.343

5.  Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery disease.

Authors:  Mary McGrae McDermott; Lu Tian; Richard G Wunderink; Ravi Kalhan; Melina R Kibbe; Philip Greenland; Russell Tracy; Lihui Zhao; Kiang Liu; Mark Huffman; John T Wilkins; Yihua Liao; Sanjiv Shah; Donald Lloyd Jones; David Green
Journal:  Vasc Med       Date:  2016-12-15       Impact factor: 3.239

6.  Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion.

Authors:  Tufan Tükek; Pinar Yildiz; Vakur Akkaya; Mehmet Akif Karan; Dursun Atilgan; Veysel Yilmaz; Ferruh Korkut
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

7.  The effect of ivabradine on functional capacity in patients with chronic obstructive pulmonary disease.

Authors:  Kareem Mahmoud; Hussien Heshmat Kassem; Essam Baligh; Usama ElGameel; Yosri Akl; Hossam Kandil
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

Review 8.  Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Authors:  Mario Cazzola; Maria G Matera; Claudio F Donner
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Increased sympathetic nerve activity in COPD is associated with morbidity and mortality.

Authors:  Stefan Andreas; Helge Haarmann; Stephan Klarner; Gerd Hasenfuss; Tobias Raupach
Journal:  Lung       Date:  2013-12-22       Impact factor: 2.584

10.  Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function.

Authors:  Tomas Konecny; Kiran R Somers; Jae Yoon Park; Alan John; Marek Orban; Rahul Doshi; Paul D Scanlon; Samuel J Asirvatham; Charanjit S Rihal; Peter A Brady
Journal:  Heart Rhythm       Date:  2017-10-03       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.